| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $386K | +7.5% |
| R&D Expense | $27.1M | +55.7% |
| SG&A Expense | $13.2M | +11.3% |
| Operating Income | -$39.9M | -38.3% |
| Income Tax | $0 | — |
| Net Income | -$38.7M | -36.8% |
| EPS (Basic) | -$0.89 | -21.9% |
| EPS (Diluted) | -$0.89 | -21.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $16.3M | +36.9% |
| Short-term Investments | $88.9M | -31.0% |
| Accounts Receivable | $771K | +44.1% |
| Current Assets | $111.3M | -23.8% |
| Total Assets | $116.2M | -22.3% |
| Current Liabilities | $7.8M | +19.0% |
| Total Liabilities | $9.8M | +7.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$33.8M | -46.8% |
| Capital Expenditures | $1.0M | +390.7% |
| Investing Cash Flow | $38.1M | +129.0% |
| Financing Cash Flow | $75K | -99.8% |
| Free Cash Flow | -$34.8M | -49.8% |
| Stockholders' Equity |
| $106.3M |
| -24.3% |